SCHEMBL25018210

SCHEMBL25018210

CC(C)CNc1ccc(CNS(C)(=O)=O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.52
▸ ADRB1 P08588 1/20 0.52
▸ ADRB3 P13945 1/20 0.52
▸ KMT2A Q03164 1/20 0.50
▸ GHSR Q92847 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.41
▸ CA2 P00918 4/20 0.41
▸ CA1 P00915 3/20 0.41
▸ CA9 Q16790 3/20 0.41
▸ CA12 O43570 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NAMPT P43490 1/20 0.40
▸ CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8899770 0.87 ADRB2 (0.50) ADRB2ADRB1ADRB3KMT2AGHSR
SCHEMBL18660179 0.80 MEN1 (0.50) KMT2AKDM4EPOLBRECQLALDH1A1
SCHEMBL14443028 0.79 KMT2A (0.56) ADRB3KMT2AKDM4EPOLBTSHR
SCHEMBL146034 0.75 IDO1 (0.45) TSHRALDH1A1CA2CA1CA9
SCHEMBL8750065 0.75 KMT2A (0.56) KMT2AKDM4EPOLBTSHRRECQL
SCHEMBL12522061 0.75 KMT2A (0.56) ADRB2ADRB1ADRB3KMT2AKDM4E
SCHEMBL8897049 0.75 ADRB2 (0.48) ADRB2ADRB1ADRB3KMT2AKDM4E
Hydrochloric Acid SCHEMBL4348562 0.74 KMT2A (0.54) KMT2AKDM4EPOLBTSHRRECQL
SCHEMBL5308930 0.73 MEN1 (0.53) KMT2ATSHRALDH1A1CA2CA1
SCHEMBL5384653 0.73 KMT2A (0.54) ADRB2ADRB1ADRB3KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578101-B2 Proteasome inhibitors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578101-B2 Proteasome inhibitors PSMG3, PSME1, PSMB1 ADRB2 4256/4885ADRB1 3617/4885ADRB3 3806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback